Select a relevant service

To better assist you with your request, please choose a research area provided by FIECON Ltd. In case you cannot find an exact match, simply select any service, and our concierge team will swiftly address it once your request has been submitted.

Health Economics and Outcomes Research (HEOR)

Evaluate data collected during drug development to maximize the value of a therapeutic product.
Market Access

Find general strategies and methods used to market a pharmaceutical product or device.
Discovery Statistical and Mathematical Modeling

Use mathematical variables and equations to establish relationships between data.
Systematic Literature Review

Summarizes the results of research (that meet pre-defined eligibility criteria for inclusion) and provides a high level of evidence on the outcomes assessed.
Pricing Strategy

Develop value story tailored to a payer audience that will determine the appropriate price for treatment.
Decision Analytic Modeling

Assess effects, costs and economic outcomes of treatment. These include cost-effectiveness models and budget impact models.
Cost Benefit Analysis

Economic evaluation in which costs and benefits (outcomes) are expressed in monetary units, to determine if the benefits of an intervention outweigh the costs.
Value Dossiers Development

Summary document that presents clinical, economic, and humanistic value of an intervention and associated disease state with the supporting evidence, formulated from the perspective of a particular stakeholder (manufacturer, payer, provider, HTA agency, etc.). See also HTA Submission.
Health Technology Assessment Submission (HTA Submission)

Analyze the medical, social, ethical, humanistic, and economic considerations of a drug, medical device, or clinical procedures. Submissions are sent to regulatory agencies with different requirements that govern submissions. See also AMCP and Value Dossier.
Data Asset Validation

Tools for validating that patient data and source has been accurately recorded.